ALRN 6924 companion diagnostic - Aileron Therapeutics
Alternative Names: ALRN-6924 companion diagnostic - Aileron TherapeuticsLatest Information Update: 14 May 2021
At a glance
- Originator Aileron Therapeutics
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Cancer